AusPAR: Bortezomib

Australian Public Assessment Report

AusPAR

AusPAR Bortezomib [PDF, 464.53 KB]

AusPAR Bortezomib [Word, 401.73 KB]

Attachment: Product Information: Bortezomib [PDF, 785.6 KB]

Attachment: Product Information: Bortezomib [Word, 704.05 KB]

Attachment: Extract from Clinical Evaluation Report: Bortezomib [PDF, 1.25 MB]

Attachment: Extract from Clinical Evaluation Report: Bortezomib [Word, 2.62 MB]

Device/Product Name

Velcade

Active ingredients

Bortezomib

AusPAR Date

26 February 2016

Published

8 March 2016

Submission Number

PM-2014-03463-1-4

Submission Type

Extension of indications

Decision

Approved